E2F2 and non-small cell lung carcinoma: For example, B-MYB accelerates the cell cycle in colorectal cancer cells 47 by upregulating the E2F2/ERK/AKT signaling pathway, and suppressing IGFBP3 expression to promote proliferation and metastasis in non-small cell lung cancer 48.